Faster Chemoradiation with Brachytherapy for Cervical Cancer
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer
This project aims to improve cervical cancer treatment by combining a new, faster radiation approach with chemotherapy to better fight the disease and boost the body's immune response.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11179467 on NIH RePORTER |
What this research studies
Current treatments for cervical cancer haven't changed much in decades, and many patients still face challenges like the cancer returning or spreading. This new approach, called Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT), seeks to deliver radiation more effectively and quickly. Researchers believe that by speeding up the brachytherapy component and combining it with chemotherapy, they can make the treatment stronger against the cancer cells. This method also hopes to improve the body's natural defenses by creating a more favorable immune environment to fight the cancer.
Who could benefit from this research
Good fit: This research is most relevant to patients diagnosed with cervical cancer who are candidates for definitive chemoradiation therapy.
Not a fit: Patients with other types of cancer or those not eligible for chemoradiation therapy would not directly benefit from this specific treatment approach.
Why it matters
Potential benefit: If successful, this new treatment could lead to better outcomes for patients with cervical cancer by reducing recurrence and improving survival rates.
How similar studies have performed: While standard chemoradiation has been used for decades, this specific accelerated brachytherapy approach combined with immune system considerations is a novel strategy being explored.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Markovina, Stephanie — Washington University
- Study coordinator: Markovina, Stephanie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.